IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.770
-0.060 (-3.28%)
Jan 17, 2025, 4:00 PM EST - Market closed
IGM Biosciences Employees
IGM Biosciences had 224 employees as of December 31, 2023. The number of employees decreased by 34 or -13.18% compared to the previous year.
Employees
224
Change (1Y)
-34
Growth (1Y)
-13.18%
Revenue / Employee
$13,027
Profits / Employee
-$981,442
Market Cap
105.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 224 | -34 | -13.18% |
| Dec 31, 2022 | 258 | 66 | 34.38% |
| Dec 31, 2021 | 192 | 85 | 79.44% |
| Dec 31, 2020 | 107 | 43 | 67.19% |
| Dec 31, 2019 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IGMS News
- 11 days ago - IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - Market Watch
- 11 days ago - IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs - GlobeNewsWire
- 2 months ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 3 months ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 3 months ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons
- 3 months ago - IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga